- All > Medicine Information and Evidence for Policy > Medicines Policy
- All > Medicine Access and Rational Use > Rational Use
- Keywords > appropriate use
- Keywords > data collection - methods
- Keywords > health system perspective - access to medicines
- Keywords > health system strengthening
- Keywords > indicator-based approach
- Keywords > indicators for the assessment of the pharmaceutical situation
- Keywords > monitoring and evaluation
- Keywords > pharmaceutical care - integration in Health System
- Keywords > surveys
(2014; 5 pages)
This annex points the reader towards a non-exhaustive list of survey tools, data collection instruments and data sources that can be used to collect and monitor core medicines indicators. Other instruments and data sources certainly exist at international, regional and national levels, but an exhaustive inventory of those is beyond the mandate of this annex.
Medicines indicators may be collected through routine data collection systems (e.g. health insurance claims databases; hospital, clinic or pharmacy’s registries; medicines sales volumes; medicines tenders etc.) or through targeted surveys at different levels of the system (health system decision makers, health facilities, patients, households etc.).
To respond to the needs of countries in monitoring and assessing medicines situations, the WHO has developed a core set of indicators, and corresponding data collection and survey tools, to monitor countries’ pharmaceutical situations. This core package can be used by decision makers as “a guide in determining priority areas for intervention, tracking progress, planning programs, assessing program effectiveness, co-ordinating donors and raising funds”.
WHO medicines indicators’ package is divided in Level I, Level II and Level III indicators. Details can be found on WHO website at the following link: http://www.who.int/medicines/areas/policy/monitoring/en/index.htm